0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vector Manufacturing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-13J2823
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Viral Vector Manufacturing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Viral Vector Manufacturing Market Research Report 2025

Code: QYRE-Auto-13J2823
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Vector Manufacturing Market Size

The global market for Viral Vector Manufacturing was valued at US$ 532 million in the year 2024 and is projected to reach a revised size of US$ 740 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Viral Vector Manufacturing Market

Viral Vector Manufacturing Market

Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Manufacturing.
The Viral Vector Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Viral Vector Manufacturing Market Report

Report Metric Details
Report Name Viral Vector Manufacturing Market
Accounted market size in year US$ 532 million
Forecasted market size in 2031 US$ 740 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Adenoviral Vectors
  • Adeno-associated Viral Vectors
  • Retroviral Vectors
  • Lentiviral Vectors
  • Other
Segment by Application
  • Gene Therapy
  • Vaccinology
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies, Lonza, Biovian, Thermo Fisher Scientific (Brammer Bio)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Vector Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector Manufacturing Market growing?

Ans: The Viral Vector Manufacturing Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Viral Vector Manufacturing Market size in 2031?

Ans: The Viral Vector Manufacturing Market size in 2031 will be US$ 740 million.

Who are the main players in the Viral Vector Manufacturing Market report?

Ans: The main players in the Viral Vector Manufacturing Market are BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies, Lonza, Biovian, Thermo Fisher Scientific (Brammer Bio)

What are the Application segmentation covered in the Viral Vector Manufacturing Market report?

Ans: The Applications covered in the Viral Vector Manufacturing Market report are Gene Therapy, Vaccinology

What are the Type segmentation covered in the Viral Vector Manufacturing Market report?

Ans: The Types covered in the Viral Vector Manufacturing Market report are Adenoviral Vectors, Adeno-associated Viral Vectors, Retroviral Vectors, Lentiviral Vectors, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adenoviral Vectors
1.2.3 Adeno-associated Viral Vectors
1.2.4 Retroviral Vectors
1.2.5 Lentiviral Vectors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Viral Vector Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Manufacturing Market Perspective (2020-2031)
2.2 Global Viral Vector Manufacturing Growth Trends by Region
2.2.1 Global Viral Vector Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector Manufacturing Market Dynamics
2.3.1 Viral Vector Manufacturing Industry Trends
2.3.2 Viral Vector Manufacturing Market Drivers
2.3.3 Viral Vector Manufacturing Market Challenges
2.3.4 Viral Vector Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Manufacturing Players by Revenue
3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Manufacturing Revenue
3.4 Global Viral Vector Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2024
3.5 Global Key Players of Viral Vector Manufacturing Head office and Area Served
3.6 Global Key Players of Viral Vector Manufacturing, Product and Application
3.7 Global Key Players of Viral Vector Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Manufacturing Breakdown Data by Type
4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2026-2031)
5 Viral Vector Manufacturing Breakdown Data by Application
5.1 Global Viral Vector Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector Manufacturing Market Size (2020-2031)
6.2 North America Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector Manufacturing Market Size by Country (2020-2025)
6.4 North America Viral Vector Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Manufacturing Market Size (2020-2031)
7.2 Europe Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector Manufacturing Market Size by Country (2020-2025)
7.4 Europe Viral Vector Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Manufacturing Market Size (2020-2031)
9.2 Latin America Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Viral Vector Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Details
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vector Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2020-2025)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Details
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vector Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2020-2025)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2020-2025)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2020-2025)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Details
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vector Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2020-2025)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vector Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2020-2025)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Details
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vector Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2020-2025)
11.7.5 MassBiologics Recent Development
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2020-2025)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Viral Vector Manufacturing Introduction
11.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 Biovian
11.10.1 Biovian Company Details
11.10.2 Biovian Business Overview
11.10.3 Biovian Viral Vector Manufacturing Introduction
11.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2020-2025)
11.10.5 Biovian Recent Development
11.11 Thermo Fisher Scientific (Brammer Bio)
11.11.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.11.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Introduction
11.11.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2020-2025)
11.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Adenoviral Vectors
 Table 3. Key Players of Adeno-associated Viral Vectors
 Table 4. Key Players of Retroviral Vectors
 Table 5. Key Players of Lentiviral Vectors
 Table 6. Key Players of Other
 Table 7. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Viral Vector Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Viral Vector Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Viral Vector Manufacturing Market Share by Region (2020-2025)
 Table 11. Global Viral Vector Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Viral Vector Manufacturing Market Share by Region (2026-2031)
 Table 13. Viral Vector Manufacturing Market Trends
 Table 14. Viral Vector Manufacturing Market Drivers
 Table 15. Viral Vector Manufacturing Market Challenges
 Table 16. Viral Vector Manufacturing Market Restraints
 Table 17. Global Viral Vector Manufacturing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Viral Vector Manufacturing Market Share by Players (2020-2025)
 Table 19. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2024)
 Table 20. Ranking of Global Top Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Viral Vector Manufacturing, Headquarters and Area Served
 Table 23. Global Key Players of Viral Vector Manufacturing, Product and Application
 Table 24. Global Key Players of Viral Vector Manufacturing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Viral Vector Manufacturing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Viral Vector Manufacturing Revenue Market Share by Type (2020-2025)
 Table 28. Global Viral Vector Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Viral Vector Manufacturing Revenue Market Share by Type (2026-2031)
 Table 30. Global Viral Vector Manufacturing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Viral Vector Manufacturing Revenue Market Share by Application (2020-2025)
 Table 32. Global Viral Vector Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Viral Vector Manufacturing Revenue Market Share by Application (2026-2031)
 Table 34. North America Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Viral Vector Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. BioReliance Company Details
 Table 50. BioReliance Business Overview
 Table 51. BioReliance Viral Vector Manufacturing Product
 Table 52. BioReliance Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 53. BioReliance Recent Development
 Table 54. Cobra Biologics Company Details
 Table 55. Cobra Biologics Business Overview
 Table 56. Cobra Biologics Viral Vector Manufacturing Product
 Table 57. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 58. Cobra Biologics Recent Development
 Table 59. Oxford BioMedica Company Details
 Table 60. Oxford BioMedica Business Overview
 Table 61. Oxford BioMedica Viral Vector Manufacturing Product
 Table 62. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 63. Oxford BioMedica Recent Development
 Table 64. UniQure Company Details
 Table 65. UniQure Business Overview
 Table 66. UniQure Viral Vector Manufacturing Product
 Table 67. UniQure Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 68. UniQure Recent Development
 Table 69. FinVector Company Details
 Table 70. FinVector Business Overview
 Table 71. FinVector Viral Vector Manufacturing Product
 Table 72. FinVector Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 73. FinVector Recent Development
 Table 74. MolMed Company Details
 Table 75. MolMed Business Overview
 Table 76. MolMed Viral Vector Manufacturing Product
 Table 77. MolMed Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 78. MolMed Recent Development
 Table 79. MassBiologics Company Details
 Table 80. MassBiologics Business Overview
 Table 81. MassBiologics Viral Vector Manufacturing Product
 Table 82. MassBiologics Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 83. MassBiologics Recent Development
 Table 84. FUJIFILM Diosynth Biotechnologies Company Details
 Table 85. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 86. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Product
 Table 87. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 88. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 89. Lonza Company Details
 Table 90. Lonza Business Overview
 Table 91. Lonza Viral Vector Manufacturing Product
 Table 92. Lonza Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 93. Lonza Recent Development
 Table 94. Biovian Company Details
 Table 95. Biovian Business Overview
 Table 96. Biovian Viral Vector Manufacturing Product
 Table 97. Biovian Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 98. Biovian Recent Development
 Table 99. Thermo Fisher Scientific (Brammer Bio) Company Details
 Table 100. Thermo Fisher Scientific (Brammer Bio) Business Overview
 Table 101. Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Product
 Table 102. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
 Table 103. Thermo Fisher Scientific (Brammer Bio) Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Viral Vector Manufacturing Picture
 Figure 2. Global Viral Vector Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Viral Vector Manufacturing Market Share by Type: 2024 VS 2031
 Figure 4. Adenoviral Vectors Features
 Figure 5. Adeno-associated Viral Vectors Features
 Figure 6. Retroviral Vectors Features
 Figure 7. Lentiviral Vectors Features
 Figure 8. Other Features
 Figure 9. Global Viral Vector Manufacturing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Viral Vector Manufacturing Market Share by Application: 2024 VS 2031
 Figure 11. Gene Therapy Case Studies
 Figure 12. Vaccinology Case Studies
 Figure 13. Viral Vector Manufacturing Report Years Considered
 Figure 14. Global Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Viral Vector Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Viral Vector Manufacturing Market Share by Region: 2024 VS 2031
 Figure 17. Global Viral Vector Manufacturing Market Share by Players in 2024
 Figure 18. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2024
 Figure 20. North America Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Viral Vector Manufacturing Market Share by Country (2020-2031)
 Figure 22. United States Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Viral Vector Manufacturing Market Share by Country (2020-2031)
 Figure 26. Germany Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2020-2031)
 Figure 34. China Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Viral Vector Manufacturing Market Share by Country (2020-2031)
 Figure 42. Mexico Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Viral Vector Manufacturing Market Share by Country (2020-2031)
 Figure 46. Turkey Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. BioReliance Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 50. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 51. Oxford BioMedica Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 52. UniQure Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 53. FinVector Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 54. MolMed Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 55. MassBiologics Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 57. Lonza Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 58. Biovian Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 59. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Manufacturing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS